Chinese herbal medicines for hypertriglyceridaemia

被引:7
|
作者
Liu, Zhao Lan [1 ,2 ]
Li, George Q. [2 ]
Bensoussan, Alan [3 ]
Kiat, Hosen [4 ]
Chan, Kelvin [2 ,3 ]
Liu, Jian Ping [1 ]
机构
[1] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing 100029, Peoples R China
[2] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[3] Univ Western Sydney, Sch Sci & Hlth, CompleMED, Sydney, NSW, Australia
[4] Macquarie Univ, Cardiac Hlth Inst, Australian Sch Adv Med, Sydney, NSW 2109, Australia
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2013年 / 06期
关键词
RANDOMIZED-TRIALS; QUALITY;
D O I
10.1002/14651858.CD009560.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hypertriglyceridaemia is associated with many diseases including atherosclerosis, diabetes, hypertension and chylomicronaemia. Chinese herbal medicines have been used for a long time as lipid-lowering agents. Objectives To assess the effects and safety of Chinese herbal medicines for hypertriglyceridaemia. Search methods We searched a number of databases including The Cochrane Library, MEDLINE, EMBASE and several Chinese databases (all until May 2012). Selection criteria Randomised controlled trials in participants with hypertriglyceridaemia comparing Chinese herbal medicines with placebo, no treatment, and pharmacological or non-pharmacological interventions. Data collection and analysis Two review authors independently extracted data and assessed the risk of bias. Any disagreement was resolved by discussion and a decision was achieved based on consensus. We assessed trials for risk of bias against key criteria: random sequence generation, allocation concealment, blinding of participants, incomplete outcome data, selective outcome reporting and other sources of bias. Main results We included three randomised trials with 170 participants. Ninety participants were randomised to the Chinese herbal medicines groups and 80 to the comparator groups with numbers ranging from 50 to 60 participants per trial. The duration of treatment varied from four to six weeks. All the included trials were conducted in China and published in Chinese. Overall, the risk of bias of included trials was unclear. There were no outcome data in any of the trials on death from any cause, cardiovascular or cerebrovascular events, health-related quality of life, or costs. Three different herbal medicines, including Zhusuan Huoxue decoction, Huoxue Huayu Tongluo decoction, and Chushi Huayu decoction were evaluated. All three trials investigating Chinese herbal medicines treatment alone (two studies) or in combination withgemfibrozil (one study) reported results on serum triglyceride (TG) in favour of the herbal treatment. We did not perform a meta-analysis due to significant clinical heterogeneity between the studies. No relevant differences in adverse effects occurred and no serious adverse events were noted. Authors' conclusions The present systematic review suggests that Chinese herbal medicines may have positive effects on hypertriglyceridaemia. The trials did not report serious adverse effects following Chinese herbal medicines treatment. However, based on an unclear risk of bias in included studies and lack of patient-important long-term outcomes, no definite conclusion could be reached.
引用
收藏
页数:40
相关论文
共 50 条
  • [31] Microbial contamination in herbal medicines: a serious health hazard to elderly consumers
    de Sousa Lima, Carolina Miranda
    Teles Fujishima, Mayara Amoras
    Lima, Bruno de Paula
    Mastroianni, Patricia Carvalho
    Oliveira de Sousa, Francisco Fabio
    da Silva, Jocivania Oliveira
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01)
  • [32] Effects of Herbal Medicines on the Prevention and Treatment of Contact Dermatitis: A Systematic Review
    Rastegar, Sedigheh
    Heydarirad, Ghazaleh
    Aryanian, Zeinab
    Shekofteh, Maryam
    Shahbodaghi, Azam
    Fahimi, Shirin
    Goodarzi, Azadeh
    Poshtmahi, Sanaz
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2022, 51 (06) : 1210 - 1222
  • [33] PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)
    Zhang, Xuan
    Tan, Ran
    Lam, Wai Ching
    Yao, Liang
    Wang, Xiaoqin
    Cheng, Chung Wah
    Liu, Fan
    Chan, Jacky C. P.
    Aixinjueluo, Qiying
    Lau, Chung Tai
    Chen, Yaolong
    Yang, Kehu
    Wu, Taixiang
    Lyu, Aiping
    Bian, Zhaoxiang
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2020, 48 (06): : 1279 - 1313
  • [34] Traditional Chinese herbal medicine for vascular dementia
    Chan, Edwin S. Y.
    Bautista, Dianne T.
    Zhu, Yanan
    You, Yong
    Long, Jian Ting
    Li, Wenyun
    Chen, Christopher
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (12):
  • [35] An authenticity survey of herbal medicines from markets in China using DNA barcoding
    Han, Jianping
    Pang, Xiaohui
    Liao, Baosheng
    Yao, Hui
    Song, Jingyuan
    Chen, Shilin
    SCIENTIFIC REPORTS, 2016, 6
  • [36] Discrimination between Alternative Herbal Medicines from Different Categories with the Electronic Nose
    Zhan, Xianghao
    Guan, Xiaoqing
    Wu, Rumeng
    Wang, Zhan
    Wang, You
    Li, Guang
    SENSORS, 2018, 18 (09)
  • [37] An overview on adverse drug reactions to traditional Chinese medicines
    Chan, Kelvin
    Zhang, Hongwei
    Lin, Zhi-Xiu
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 834 - 843
  • [38] Possibilities and limitations of European and Chinese herbal medicine in oncology
    Beer, Andre-Michael
    Huebner, Jutta
    ONKOLOGE, 2017, 23 (03): : 190 - 195
  • [39] Health, safety and quality concerns of plant-based traditional medicines and herbal remedies
    van Wyk, Anne S.
    Prinsloo, Gerhard
    SOUTH AFRICAN JOURNAL OF BOTANY, 2020, 133 : 54 - 62
  • [40] Integrating modern and herbal medicines in controlling malaria: experiences of orthodox healthcare providers in Ghana
    Ampomah, Irene G.
    Ampomah, Genevieve A.
    Emeto, Theophilus I.
    ARCHIVES OF PUBLIC HEALTH, 2024, 82 (01)